ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2071

Expression of Neuraminidase 1 (NEU1) Is Upregulated in the Lungs of Scleroderma Patients with Pulmonary Fibrosis, and Gene Delivery of NEU1 to Mouse Lungs Elicits Accumulation of CD8+ Lymphocytes and Collagen

Irina G. Luzina1,2, Anne E. Wyman1,2, Virginia Lockatell2, Zahid Noor2, Nevins W. Todd1,2, Simeon E. Goldblum1,2 and Sergei P. Atamas1,2, 1Baltimore VA Medical Center, Baltimore, MD, 2University of Maryland School of Medicine, Baltimore, MD

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Fibroblasts, fibrosis, Lung Disease, lymphocytes and scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics I

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:  We and others have previously reported that pulmonary fibrosis in patients with scleroderma is accompanied by pulmonary accumulation of predominantly CD8+ T lymphocytes. Earlier reports also suggested that NEU1, a sialidase that removes terminal sialic acid from glycoproteins, is associated with and may contribute to both fibrotic changes and immune disturbances in the lungs, but the mechanistic details of such contributions remain unclear.

Methods:  Immunohistochemical analyses were used to analyze NEU1 expression in the lung of patients with scleroderma and healthy controls. Cell culture studies were performed in normal adult primary pulmonary fibroblasts (PF). Overexpression of human NEU1 in mouse lungs in vivo and in cultured human lung fibroblasts was performed utilizing a replication-deficient recombinant adenovirus. In PF cell cultures, the effect of NEU1 overexpression on the levels of type I collagen protein were assessed utilizing western blotting. In the in vivo experiments, total and differential bronchoalveolar lavage (BAL) cells counts, flow cytometry of BAL cells, immunohistochemistry of lung tissues, trichrome staining for collagen, and total lung collagen measurements were utilized to characterize NEU1 overexpression-induced changes.

Results:  NEU1 was expressed in airway epithelial cells, endothelial cells, and parenchymal cells in all tested lung tissue samples, but the expression was more pronounced in the lungs of scleroderma patients with pulmonary fibrosis. Western blot analyses revealed a strong increase in NEU1 expression in cultured PF from patients with scleroderma compared to healthy controls. NEU1 overexpression in normal fibroblast cultures led to a significant elevation in collagen levels, without increasing TGF-β mRNA or total or active TGF-β protein. Simultaneously, overexpression of NEU1 caused autocatalytic proteolysis of MMP14, a collagen-degrading enzyme, whose desialylation state is known to accelerate self-proteolysis. Intratracheal instillation of a NEU1-encoding but not a control adenovirus in mice in vivo caused accumulation of lymphocytes in BAL and lung tissue, elevation in total pulmonary TGF-β, and increases in pulmonary collagen. The accumulating lymphocytes were predominantly T cells, with CD8+ cells exceeding CD4+ cells by nearly 2 fold.

Conclusion:  NEU1 expression is elevated in the lungs of scleroderma patients with pulmonary fibrosis, contributing to collagen protein accumulation by activating autocatalytic proteolysis of the collagen-degrading enzyme MMP14. In vivo, NEU1 gene delivery causes pulmonary fibrosis and lymphocytosis with predominant accumulation of CD8+ T cells, which are also seen in patients with scleroderma lung disease. Together, these data suggest an important pathophysiological role for NEU1 in pulmonary abnormalities observed in patients with scleroderma.


Disclosure: I. G. Luzina, None; A. E. Wyman, None; V. Lockatell, None; Z. Noor, None; N. W. Todd, None; S. E. Goldblum, None; S. P. Atamas, None.

To cite this abstract in AMA style:

Luzina IG, Wyman AE, Lockatell V, Noor Z, Todd NW, Goldblum SE, Atamas SP. Expression of Neuraminidase 1 (NEU1) Is Upregulated in the Lungs of Scleroderma Patients with Pulmonary Fibrosis, and Gene Delivery of NEU1 to Mouse Lungs Elicits Accumulation of CD8+ Lymphocytes and Collagen [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/expression-of-neuraminidase-1-neu1-is-upregulated-in-the-lungs-of-scleroderma-patients-with-pulmonary-fibrosis-and-gene-delivery-of-neu1-to-mouse-lungs-elicits-accumulation-of-cd8-lymphocytes-and/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/expression-of-neuraminidase-1-neu1-is-upregulated-in-the-lungs-of-scleroderma-patients-with-pulmonary-fibrosis-and-gene-delivery-of-neu1-to-mouse-lungs-elicits-accumulation-of-cd8-lymphocytes-and/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology